SCHEMBL31435213

SCHEMBL31435213

C=CCO/N=C1/C[C@H]2[C@](C)(C(=O)O)CCC[C@]2(C)c2cc(Cl)c(C(C)C)c(Cl)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.38
▸ RXRB P28702 2/20 0.38
▸ RXRG P48443 2/20 0.38
▸ KARS1 Q15046 2/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ NR1I2 O75469 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ POLA1 P09884 4/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ NR1H3 Q13133 4/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ NR1H2 P55055 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20360179 0.87 KARS1 (0.42) RXRARXRBRXRGKARS1CCNE1
SCHEMBL20360180 0.87 KARS1 (0.42) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17934309 0.86 KARS1 (0.40) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17927266 0.85 NR1I2 (0.39) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17934310 0.85 NR1I2 (0.39) RXRARXRBRXRGKARS1CCNE1
SCHEMBL20366968 0.80 KARS1 (0.40) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17927240 0.80 KARS1 (0.38) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17927242 0.80 KARS1 (0.38) RXRARXRBRXRGKARS1CCNE1
SCHEMBL20359256 0.80 KARS1 (0.42) RXRARXRBRXRGKARS1CCNE1
SCHEMBL17934294 0.80 KARS1 (0.42) RXRARXRBRXRGKARS1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12350312-B2 Methods for improving adoptive cell therapy FRED HUTCHINSON CANCER CENTER (US) 2025-07-08 — — US disclosed
WO-2025090981-A1 IDENTIFICATION OF THERAPEUTIC TARGETS FOR BIPOLAR DISORDER THE JOHNS HOPKINS UNIVERSITY (US) 2025-05-01 — — WO disclosed
Send feedback